🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of acetaminophen, claiming the firms hid alleged dangers that the drug posed to pediatric neurological development.

The lawsuit comes thirty days after Former President Trump advocated an unsubstantiated connection between taking Tylenol - also known as acetaminophen - during pregnancy and autism in children.

Paxton is suing J&J, which formerly manufactured the medication, the sole analgesic suggested for women during pregnancy, and the current manufacturer, which currently produces it.

In a statement, he stated they "deceived the public by gaining financially from pain and marketing drugs ignoring the potential hazards."

The manufacturer says there is lacking scientific proof connecting Tylenol to autism.

"These manufacturers lied for decades, intentionally threatening numerous people to line their pockets," the attorney general, a Republican, stated.

Kenvue commented that it was "deeply concerned by the perpetuation of misinformation on the reliability of acetaminophen and the likely effects that could have on the health of American women and children."

On its online platform, Kenvue also said it had "continuously evaluated the applicable studies and there is insufficient valid information that indicates a proven link between using acetaminophen and autism."

Groups acting on behalf of medical professionals and medical practitioners concur.

The leading OB-GYN organization has said paracetamol - the key substance in acetaminophen - is one of the few options for expectant mothers to treat discomfort and elevated temperature, which can pose significant medical dangers if not addressed.

"In multiple decades of studies on the consumption of acetaminophen in gestation, zero credible investigations has conclusively proven that the use of paracetamol in any trimester of pregnancy leads to brain development issues in offspring," the group commented.

The court filing mentions current declarations from the Trump administration in claiming the drug is allegedly unsafe.

In recent weeks, Trump raised alarms from health experts when he instructed pregnant women to "fight like hell" not to consume Tylenol when unwell.

The US Food and Drug Administration then published an announcement that physicians should contemplate reducing the consumption of Tylenol, while also mentioning that "a proven link" between the medication and autism spectrum disorder in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who oversees the Food and Drug Administration, had promised in April to initiate "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a limited time.

But authorities warned that discovering a unique factor of autism - considered by experts to be the result of a complicated interplay of genetic and external influences - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and disability that affects how persons experience and interact with the world, and is recognized using doctors' observations.

In his legal document, Paxton - aligned with the former president who is campaigning for US Senate - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism spectrum disorder.

The case aims to force the companies "destroy any marketing or advertising" that asserts Tylenol is reliable for women during pregnancy.

The court case echoes the complaints of a assembly of mothers and fathers of young ones with autism spectrum disorder and ADHD who took legal action against the manufacturers of Tylenol in 2022.

Judicial authorities threw out the lawsuit, saying research from the parents' expert witnesses was lacking definitive proof.